chat

Xbrane Biopharma AB - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you are employed by Xbrane Biopharma AB and you wish to licence your ESG rating, please contact us. The dashboard contains a Q&A section about Xbrane Biopharma AB. This webpage displays a zero-cost ESG assessment covering Xbrane Biopharma AB.

Xbrane Biopharma AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 1.6, social score of 4.0 and governance score of 3.0.

green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

SDG Transparency Score for Xbrane Biopharma AB 

2.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2022-07-01
What drives the score for Xbrane Biopharma AB 
1.6

Environmental

4.0

Social

3.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.8
High
2Eli Lilly and Co
9.5
High
.........
2028Yungjin Pharm Co Ltd
3.0
Medium
2028Tenth of Ramadan for Pharmaceutical and Diagnostic Reagents Company SAE
3.0
Medium
2062Xbrane Biopharma AB
2.9
Medium
2062Cyxone AB
2.9
Medium
2062Legend Biotech Corp
2.9
Medium
.........
2690Zyden Gentec Ltd
0.0
Low
2690Zyla Life Sciences
0.0
Low
.........
View the full peer group of 3274 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Xbrane Biopharma AB reference operational or capital allocation in relation to climate change?No
No answer found for the question
Does the Board describe its role in the oversight of climate-related risks and opportunities?No
No answer found for the question

Is Capital Expenditure linked to emissions reduction?

Only SubscribersSubscription required

Has Xbrane Biopharma AB submitted or committed to submit to a shareholder vote (say-on-climate) its climate strategy?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose current and historical air emissions?

Does Xbrane Biopharma AB disclose current and / or historical ozone-depleting emissions?

LockedSign up for free to unlock
Does Xbrane Biopharma AB disclose current and / or historical scope 1 emissions?
Does Xbrane Biopharma AB disclose current and / or historical scope 2 emissions?

Does Xbrane Biopharma AB disclose current and / or historical scope 3 emissions?

Only SubscribersSubscription required

Does Xbrane Biopharma AB disclose current and / or historical emissions broken down by scope?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose GHG and Air Emissions intensity?

Does Xbrane Biopharma AB disclose GHG Targets?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose data for NOx, SOx and VOCs emissions?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its Scope Emissions targets?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose current and historical energy intensity?

Does Xbrane Biopharma AB disclose its current and / or historical energy use?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose energy use targets?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its Renewable Energy targets?

Only SubscribersSubscription required

Does Xbrane Biopharma AB disclose its biodiversity policy?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its forestry policy?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its internal carbon price?

Only SubscribersSubscription required

Does Xbrane Biopharma AB disclose long-term targets (>5 years) for reducing its GHG emissions?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose Scope 3 emissions from use of sold products?

Only SubscribersSubscription required

Does Xbrane Biopharma AB disclose current and historical material use?

LockedSign up for free to unlock
Are Operating Expesnses linked to emissions reduction?
Does Xbrane Biopharma AB disclose climate scenario or pathway analysis?
Does Xbrane Biopharma AB reflect climate-related risks in its financial statements?

Does Xbrane Biopharma AB disclose the number and percentage of companies screened by environmental and social criteria?

Only SubscribersSubscription required

Are emissions metrics verified by CDP?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required
Does Xbrane Biopharma AB report according to TCFD requirements?

Does Xbrane Biopharma AB disclose current and historical waste generation?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose current and / or historical waste management?

Only SubscribersSubscription required

Does Xbrane Biopharma AB disclose waste targets?

Only SubscribersSubscription required

Has Xbrane Biopharma AB published clear targets on waste management?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose current and / or historical water consumption?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose its waste policy?
Does Xbrane Biopharma AB disclose water use targets?
Does Xbrane Biopharma AB condunt supply chain audits?

Does Xbrane Biopharma AB engage third parties to conduct supply chain audit?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose board meeting attendance?

LockedSign up for free to unlock

Are there worker representatives on the board?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose long term financial targets?

Only SubscribersSubscription required

Does Xbrane Biopharma AB report NPS (customer loyalty, customer churn or satisfaction surveys) ?

LockedSign up for free to unlock

Does Xbrane Biopharma AB report customer churn rates?

Only SubscribersSubscription required

Does Xbrane Biopharma AB have a policy relating to cyber security?

LockedSign up for free to unlock
Does Xbrane Biopharma AB disclose cybersecurity risks?

Does Xbrane Biopharma AB adhere to ISO 27001 / ISO 27002 standards or the NIST cybersecurity framework?

Only SubscribersSubscription required

Does Xbrane Biopharma AB conduct cybersecurity training?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose the individual responsible for D&I?
Does Xbrane Biopharma AB conduct 360 degree staff reviews?

Does Xbrane Biopharma AB have engagement surveys, a culture survey, a pulse survey?

LockedSign up for free to unlock
Does Xbrane Biopharma AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

Does Xbrane Biopharma AB disclose the vesting percentage required for performance threshold in the LTIP?

Only SubscribersSubscription required
Has Xbrane Biopharma AB issued a profit warning in the past 24 months?
Does Xbrane Biopharma AB report the average age of the workforce?

Does Xbrane Biopharma AB report internal employee trust metrics such as ENPS?

LockedSign up for free to unlock

Does Xbrane Biopharma AB permit its workforce to engage in collective bargaining?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose average employee tenure?

Only SubscribersSubscription required

Does Xbrane Biopharma AB refer to human capital or people risk in its risk disclosures?

Only SubscribersSubscription required

Does Xbrane Biopharma AB promote decent work conditions in relation to its supply chain?

LockedSign up for free to unlock
Does Xbrane Biopharma AB allow for Work Councils/Collective Agreements to be formed?

Does Xbrane Biopharma AB report the number of strikes or work related stoppages?

LockedSign up for free to unlock
Does Xbrane Biopharma AB have an accelerator or VC vehicle to help deliver innovation?

Does Xbrane Biopharma AB have a chief innovation officer?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the ratio of CEO total compensation relative to average employee compensation ?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose its gender pay gap?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose its ethnicity pay gap?
Does Xbrane Biopharma AB disclose the number of employees in R&D functions?

Does Xbrane Biopharma AB engage in animal testing?

Only SubscribersSubscription required
Does Xbrane Biopharma AB engage in stem cell research?

Does Xbrane Biopharma AB have a commitment to a living wage?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the vesting schedule of its equity compensation plan?

LockedSign up for free to unlock
Is executive remuneration linked to climate performance?
Does Xbrane Biopharma AB offer flexible work?

Does Xbrane Biopharma AB disclose employee diversity metrics?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose employee gender diversity metrics?

LockedSign up for free to unlock
Does Xbrane Biopharma AB disclose the pay ratio of women to men?
Does Xbrane Biopharma AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

Does Xbrane Biopharma AB disclose information on fatalities and accidents in the workplace

Only SubscribersSubscription required
Does Xbrane Biopharma AB report instances of occupational ill health, injury and fatality?

Does Xbrane Biopharma AB disclose reportable workplace incidents?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the number of employees, new hires and turnover metrics?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose parental leave metrics?

Does Xbrane Biopharma AB disclose employee training metrics?

LockedSign up for free to unlock
Does Xbrane Biopharma AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Xbrane Biopharma AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

Does Xbrane Biopharma AB disclose the number of customer privacy complaints?

Only SubscribersSubscription required
Does Xbrane Biopharma AB disclose incidents of discrimination?

Does Xbrane Biopharma AB disclose incidents relating human rights, child labour and forced labour?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose incidents of corruption?

Only SubscribersSubscription required

Does Xbrane Biopharma AB disclose the number of incidents involving the rights of indigenous peoples?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose incidents of non-compliance in relation to product and service information/labelling or marketing communications?

Only SubscribersSubscription required
Did Xbrane Biopharma AB have a product recall in the last two years?
Does Xbrane Biopharma AB support suppliers with sustainability related research and development?
Does Xbrane Biopharma AB have careers partnerships with academic institutions?
Is Xbrane Biopharma AB involved in embryonic stem cell research?

Does Xbrane Biopharma AB avoid gender bias in its hiring?

LockedSign up for free to unlock

Does Xbrane Biopharma AB disclose the number of hours and/or employees/security personnel trained on human rights policies or procedures?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Xbrane Biopharma AB
These potential risks are based on the size, segment and geographies of the company.

Do you want to create your own ESG Scorecard that you can share with your team members?

Sign up for free
ESG Scorecard with Trendline
green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Xlucane, a ranibizumab biosimilar that is in Phase III clinical trials used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic related retinopathy, and retinal vein occlusion. Its pre-clinical phase products include Xcimzane for rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis and crohn diseases; Xoncane for acute lymphocytic leukemia; Spherotide for prostate cancer, breast cancer, endometriosis, and myoma; and Xdivane for melanoma, lung, head and throat, bladder, and urinary tract cancer, as well as for renal cell carcinoma. The company has a strategic biosimilar development partnership with STADA Arzneimittel AG to evaluate development and commercialization collaborations around its Xcimzane and Xdivane preclinical biosimilars. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.